Substance / Medication

Dihydrotachysterol

Overview

Active Ingredient
dihydrotachysterol
RxNorm CUI
3429

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

17 trials linked to this intervention

17
Total Trials
2
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children.
Chibuzor Moriam T, Graham-Kalio Diepiriye, Osaji Joy O et al. · Cochrane Database Syst Rev · 2020
PMID: 32303107Meta-AnalysisFull text (PMC)
Rickets in association with skin diseases and conditions: A review with emphasis on screening and prevention.
Litaiem Noureddine, Chabchoub Ines, Bacha Takwa et al. · Photodermatol Photoimmunol Photomed · 2020
PMID: 32645757Meta-Analysis
F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature.
Evangelista Laura, Ravelli Ilaria, Magnani Fabio et al. · Ann Nucl Med · 2020
PMID: 32767248Meta-AnalysisFull text (PMC)
Cost-Effectiveness of Vitamin D Supplementation in Pregnant Woman and Young Children in Preventing Rickets: A Modeling Study.
Floreskul Vilius, Juma Fatema Z, Daniel Anjali B et al. · Front Public Health · 2020
PMID: 33014962Meta-AnalysisFull text (PMC)
Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health.
Tan May Loong, Abrams Steven A, Osborn David A · Cochrane Database Syst Rev · 2020
PMID: 33305822Meta-AnalysisFull text (PMC)
The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery.
Taterra Dominik, Wong Linda M, Vikse Jens et al. · Langenbecks Arch Surg · 2019
PMID: 30762091Meta-AnalysisFull text (PMC)
Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis.
Liu Yang, Liu Ling-Yun, Jia Ye et al. · Drug Des Devel Ther · 2019
PMID: 30992658Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dihydrotachysterol (substance)
SNOMED CT
126235007
UMLS CUI
C0012319
RxNorm CUI
3429

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
17
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.